 NEW YORK (360Dx) – Drawbridge Health and Thorne Research announced today a partnership to improve blood collection tools.
The collaboration will provide Thorne Research, and its subsidiary WellnessFX, with access to Drawbridge Health's proprietary technology solution to integrate blood draw, collection, and sample stabilization in a single device. Drawbridge Health is developing a blood-draw tool aimed at broadening access to diagnostic testing and providing a convenient way to monitor overall health. Drawbridge intends to seek clearance from the US Food and Drug Administration for the blood collection system. The two companies each provide healthcare diagnostic technology platforms for healthcare consumers.
 Under the terms of the agreement, Thorne Research will receive exclusive rights to distribute and commercialize future Drawbridge Health products in the US. In exchange, Thorne Research has agreed to a multimillion dollar investment into Drawbridge Health, and Paul Jacobson, CEO of Thorne Research, is joining the Drawbridge board of directors.
Â
Â